- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Apogee Therapeutics Inc (APGE)
Apogee Therapeutics Inc stock price live, this page displays NASDAQ APGE stock exchange data. View the APGE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apogee Therapeutics Inc real time stock price chart below.
What Is the Apogee Therapeutics Inc Stock Price Today?
The Apogee Therapeutics Inc stock price today is 39.31.
What Is the Stock Symbol for Apogee Therapeutics Inc?
The stock symbol for Apogee Therapeutics Inc is "APGE."
What Stock Exchange Does Apogee Therapeutics Inc Trade On?
Apogee Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Apogee Therapeutics Inc a Good Stock to Buy?
Determining whether Apogee Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APGE quote. (ISIN: US03770N1019)
What Is the Apogee Therapeutics Inc Stock Price Today?
The Apogee Therapeutics Inc stock price today is 39.31.
What Is the Stock Symbol for Apogee Therapeutics Inc?
The stock symbol for Apogee Therapeutics Inc is "APGE."
What Stock Exchange Does Apogee Therapeutics Inc Trade On?
Apogee Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Apogee Therapeutics Inc a Good Stock to Buy?
Determining whether Apogee Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APGE quote. (ISIN: US03770N1019)
NASDAQ
Currency in USD
39.31
+0.31(+0.79%)
Closed·
After Hours
39.10-0.20(-0.51%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.58
40.40
52 wk Range
26.20
63.50
APGE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
APGE is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.5840.40
52 wk Range
26.2063.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
APGE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
96.75
Upside
+146.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Apogee Therapeutics Inc Company Profile
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
Compare APGE to Peers and Sector
Metrics to compare | APGE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPGEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.2x | −4.4x | −0.5x | |
PEG Ratio | 0.43 | 0.02 | 0.00 | |
Price/Book | 3.4x | 3.8x | 2.6x | |
Price / LTM Sales | - | 8.7x | 3.2x | |
Upside (Analyst Target) | 141.7% | 150.3% | 44.3% | |
Fair Value Upside | Unlock | 12.3% | 6.6% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 96.75
(+146.12% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.95 / -0.58
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Apogee Therapeutics (APGE) Stock Price Today?
The Apogee Therapeutics stock price today is 39.31
What Stock Exchange Does Apogee Therapeutics Trade On?
Apogee Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Apogee Therapeutics?
The stock symbol for Apogee Therapeutics is "APGE."
What Is the Apogee Therapeutics Market Cap?
As of today, Apogee Therapeutics market cap is 2.29B.
What Is Apogee Therapeutics's Earnings Per Share (TTM)?
The Apogee Therapeutics EPS (TTM) is -3.59.
When Is the Next Apogee Therapeutics Earnings Date?
Apogee Therapeutics will release its next earnings report on 31 Aug 2025.
From a Technical Analysis Perspective, Is APGE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Apogee Therapeutics Stock Split?
Apogee Therapeutics has split 0 times.
How Many Employees Does Apogee Therapeutics Have?
Apogee Therapeutics has 196 employees.
What is the current trading status of Apogee Therapeutics (APGE)?
As of 19 July 2025, Apogee Therapeutics (APGE) is trading at a price of 39.31, with a previous close of 39.00. The stock has fluctuated within a day range of 38.58 to 40.40, while its 52-week range spans from 26.20 to 63.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.